{
    "2020-09-07": [
        [
            {
                "time": "2020-09-07",
                "original_text": "双创行情速递——创业板50 vs科创50",
                "features": {
                    "keywords": [
                        "创业板50",
                        "科创50",
                        "行情"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "创业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "爱尔眼科（300015）：视光业务恢复亮眼 扩张布局稳步推进",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "视光业务",
                        "扩张布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "农银汇理创新医疗混合基金最新净值跌幅达2.71％",
                "features": {
                    "keywords": [
                        "农银汇理",
                        "创新医疗",
                        "净值跌幅"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "山西证券改革精选灵活配置混合基金最新净值跌幅达2.01％",
                "features": {
                    "keywords": [
                        "山西证券",
                        "改革精选",
                        "净值跌幅"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-01",
                "original_text": "国泰君安证券：医药股二季度恢复符合预期 9月初估值较前期高点已有明显回落",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "医药股",
                        "估值回落"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药分析框架系列报告（1）：时间的玫瑰：三类核心竞争力",
                "features": {
                    "keywords": [
                        "医药",
                        "核心竞争力",
                        "分析框架"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：二季度业绩回暖，关注创新药、器械及服务板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "业绩回暖",
                        "创新药",
                        "器械",
                        "服务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】医药行业9月投资策略暨财报总结",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "财报总结"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "QFII二季度新进151股 中国建筑被增持最多",
                "features": {
                    "keywords": [
                        "QFII",
                        "中国建筑",
                        "增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "建筑"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "食品医药板块退潮 消费股天花板到了吗？",
                "features": {
                    "keywords": [
                        "食品医药",
                        "消费股",
                        "退潮",
                        "天花板"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品",
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}